Increased Levels of Immune Inhibitory Cd34⁺ Progenitor Cells in the Peripheral Blood of Patients with Node Positive Headc and Neck Squamous Cell Carcinomas and The Ability of These CD34⁺ Cells to Differentiate Into Immune Stimulatory Dendritic Cells

Abstract

Differentiation of tumor-mobilized CD34+ cells into dendritic cells may be an immunotherapeutic approach to stimulate antitumor reactivity.